top of page

Part 2: Resolving the "Battle Royale" Between Oncologists and Payers in Bringing Precision Oncology to Patients

In this 45-minute webinar you'll hear how one of the most innovative PBMs in the country is leading in oncology care through subject matter expert Simone Ndujiuba, Director of Strategy at MagellanRx Management. She is joined by Clynt Taylor, President of Trapelo Health, and together they discuss how we can a create modern value-based care environment centered around transparency to ensure cancer patients are getting access to the latest and most appropriate precision testing and targeted therapies available today.

Play webinar below >

About the Presenter


Simone Ndujiuba, PharmD, BCOP
Director Clinical Strategy + Innovation Oncology, Magellan Rx Management

In her role at Magellan Rx, Simone focuses on serving as a subject matter expert in oncology in a customer-facing role and supports product development and innovation efforts. Simone has served as a clinical pharmacist at various medical centers and most recently has been a clinical pharmacy specialist in hematology and oncology at Memorial Hermann Hospital in the Texas Medical Center.  Simone led a team of clinical specialists in a hospital-based cancer center responsible for developing and implementing cost savings initiatives in oncology. In addition, she serves as a preceptor for the Academy of Managed Care Pharmacists (AMCP) Foundation Health Inequities summer internship program.


Simone graduated from University of Houston College of Pharmacy with a Doctor of Pharmacy and completed a residency with a managed care focus. She also is a Board Certified Oncology Pharmacist.


Related Content 

Watch Part 1 of the Battle Royale Webinar Series


Related Podcast Episodes: 
#46 Dr. Caroline Carney: Managing the Total Cost of Care in Precision Medicine

#52 Alva10 Leaders: Then and Now: The Progress of Precision Medicine

Request a Trapelo Demo
See our evidence-supported knowledgebase and order management platform for all major cancer types.

How can we resolve the complexities of using precision medicine for cancer care?

Trapelo knows.

bottom of page